Springer Nature announces fourth transformative agreement for its flagship Nature titles - September 2, 2022
Springer Nature and the FinELIB consortium have agreed a three year open access (OA) deal for the publishers’ flagship title Nature and the Nature research journals. This marks the latest transformative agreement (TA) for the publisher’s highly selective titles following agreements with Bibsam, CDL… Read More
SSP events to discuss the future of and new directions in scholarly publishing - September 2, 2022
The Society for Scholarly Publishing (SSP) will be hosting ‘The Future of Scholarly Publishing: Three Trends to Be Ready For,’ seminar on September 15 at 11:00 am ET. Moderated by Shirley Decker-Lucke, Content Director, SSRN, Elsevier), speakers Ann Gabriel (SVP Global Strategic Networks, Elsevier),… Read More
Clarivate appoints Jonathan Gear as Chief Executive Officer and Andrew Snyder as the new chair - September 2, 2022
Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, has announced that Jonathan Gear has assumed the role of Chief Executive Officer with the retirement of Jerre Stead from that role. As previously announced in July, Mr. Stead… Read More
BMC unveils new journal, BMC Global and Public Health, to advance SDG research - September 2, 2022
A pioneer of open access publishing, BMC has announced the upcoming launch of the new selective BMC journal BMC Global and Public Health, to sit alongside BMC’s renowned and leading journals BMC Medicine and BMC Biology. In light of the… Read More
BioOne adds Insect Systematics and Diversity (ISD) to the BioOne Complete collection for 2023 - September 2, 2022
BioOne has announced the addition of Insect Systematics and Diversity (ISD) to the BioOne Complete collection for 2023. This is the fifth journal to be included from the Entomological Society of America (ESA), one of BioOne Complete’s most highly-read and cited publishers. ISD will include all issues… Read More
Endocrine Society appoints Steven Meyers as Chief Strategy Officer - September 2, 2022
The Endocrine Society has announced Dr. Steven R. Meyers,—an association executive with more than a decade of experience in strategic thinking and transforming and expanding operations—to serve as its Chief Strategy Officer. As Chief Strategy Officer, Meyers will oversee the alignment of the Society’s strategic planning… Read More
